1. A comparative study of interferon oc-2b for the treatment of chronic hepatitis C;Hino, K.; Suzuki, H.; Yamamoto, Y.; Iino, S.; Ogawa, N.;Kiso-to-Rinsho (Clin Report),1992
2. Guyer DR, Tiedeman J, Yannuzzi LA, Slakter JS, Parke D, Kelley J, et al. Interferon-associated retinopathy. Arch Ophthalmol 1993; 111: 350-6.
3. Ophthalmic manifestations of interferon therapy in eight patients;Isaka, Y.; Nishi, Y.; Ito, Y.; Seki, K.;Folia Ophthalmol Jpn,1993
4. Interferon alfa-2b for subfoveal neovascularization in agerelated macular degeneration;Poliner, L.S.; Tornambe, P.E.; Michelson, P.E.; Heitzmann, J.C.J.;Ophthalmology,1993
5. Retinal vascular lesions in patients undei systemic interferon therapy;Imaizumi, H.; Takeda, M.; Okushiba, U.; Abe, N.; Tamiya, M.; Nakahira, Y.;Rinsho Ganka,1994